A real-world, non-interventional, prospective study of the effectiveness and safety of apremilast in bio-naïve adults with moderate plaque psoriasis treated in the routine care in Greece - the 'APRAISAL' study.
Demetrios IoannidesN AntonakopoulosV ChasapiC OikonomouEleftheria TampouratziE LazaridouDimitrios RigopoulosO NeofotistouA DrososG AnastasiadisE RovithiC KalinouEvangelina PapadavidP AronisM PapageorgiouA ProtopapaI BassukasI LefakiEfterpi ZafiriouK KrasagakisE PokasZ AnagnostopoulosA KekkiM PapakonstantisPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Apremilast is a safe and effective treatment for bio-naïve patients with moderate psoriasis and specific psoriasis manifestations.